Neil Butler

Neil joined Radisens’ Board in July 2011, bringing many years’ experience of entrepreneurship and management in the global medical diagnostics industry. He is a member of the board of other IVD companies including QuantuMDx and Spectromics, and is a member of the Supervisory Board of Genomic Vision. He was previously Chairman of Atlas Genetics (now Binx Health) from 2012 to 2018.

In 2004, Neil was the founding CEO of Vivacta, developing the company from a technology into a successful point of care diagnostic company. He completed successive financing rounds raising in excess of $25m, in 2012 Novartis acquired the business as a companion diagnostic. Prior to Vivacta in 1999, he teamed up with four Oxford University academics to form Oxford Biosensors. From being the first employee, Neil took Oxford Biosensors through five years of development and pilot manufacturing development on the outskirts of Oxford.

Prior to this, he was VP of Electronic Films, a division of Rexam Plc, based in North Carolina. Neil relocated to the US in order to develop key strategic opportunities for this global electronics and medical-focused business. Before moving to the US, he was Sales and Marketing Director for Rexam Plc’s European coated films business, which had four European facilities that developed electronics, wound care and transdermal drug delivery applications.

Neil holds a BSc in Engineering.